Somalogic Inc - Asset Resilience Ratio
Somalogic Inc (SLGC) has an Asset Resilience Ratio of 26.23% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of Somalogic Inc for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2022)
This chart shows how Somalogic Inc's Asset Resilience Ratio has changed over time. See shareholders equity of Somalogic Inc for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Somalogic Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see SLGC company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $148.24 Million | 26.23% |
| Total Liquid Assets | $148.24 Million | 26.23% |
Asset Resilience Insights
- Very High Liquidity: Somalogic Inc maintains exceptional liquid asset reserves at 26.23% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Somalogic Inc Industry Peers by Asset Resilience Ratio
Compare Somalogic Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Longmaster Information Tech
SHE:300288 |
Health Information Services | 0.68% |
|
Echoiq Ltd
AU:EIQ |
Health Information Services | 11.12% |
|
ARTRYA Ltd
AU:AYA |
Health Information Services | 48.49% |
|
Pharmx Technologies Ltd
AU:PHX |
Health Information Services | 22.16% |
|
Intelicare Holdings Ltd
AU:ICR |
Health Information Services | 64.05% |
|
Global Health Ltd
AU:GLH |
Health Information Services | 9.84% |
|
Pro Medicus Ltd
AU:PME |
Health Information Services | 54.64% |
|
Cogstate Ltd
AU:CGS |
Health Information Services | 54.90% |
Annual Asset Resilience Ratio for Somalogic Inc (2019–2022)
The table below shows the annual Asset Resilience Ratio data for Somalogic Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 18.19% | $117.76 Million | $647.37 Million | -12.71pp |
| 2021-12-31 | 30.90% | $218.22 Million | $706.10 Million | +14.41pp |
| 2020-12-31 | 16.49% | $39.95 Million | $242.29 Million | -27.71pp |
| 2019-12-31 | 44.20% | $31.50 Million | $71.26 Million | -- |
About Somalogic Inc
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for its cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in … Read more